Thomas Ronan Kennedy insider trades: cbdMD (YCBD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 3, 2023 | YCBD | ↑ Buy | 5,000 | $2.10 | $11K | Direct | May 5, 2023 (2d) |
| Aug 24, 2021 | YCBD | ↑ Buy | 7,400 | $2.04 | $15K | Direct | Aug 25, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other YCBD insiders
Open-market trades in the last 12 months
About Thomas Ronan Kennedy's insider trades
Thomas Ronan Kennedy is CEO and CFO at cbdMD (YCBD). Since Aug 24, 2021, Thomas has reported 2 open-market purchases worth $26K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), other transactions (3 filings), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every YCBD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.